Print Page     Close Window     

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
31 July 2018
Appendix 4C - quarterly
18 July 2018
Initial Director's Interest Notice
17 July 2018
MSB Enters Into Cardiovascular Alliance For China With Tasly
11 July 2018
Director Appointment/Resignation
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$1.55
Change : Stock is Down 0.06 (3.73%)
Volume :1,077,555
Data as of 17 August 2018 4:10 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation Financial Results for the Period Ended September 30, 2017
Download Documentation 2017 Annual Report
Download Documentation Financial Results for the Three Months and for the Year Ended June 30, 2017
Download Documentation Third Quarter Results Presentation
E-mail Alerts
Sign up to receive e-mail alerts.

Copyright © 2015 Mesoblast Inc.